Related references
Note: Only part of the references are listed.Activity of paromomycin against Leishmania amazonensis: Direct correlation between susceptibility in vitro and the treatment outcome in vivo
Elizabeth M. Coser et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2020)
Topical paromomycin for New World cutaneous leishmaniasis
Nestor Sosa et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
What makes mucosal and anergic diffuse cutaneous leishmaniases so clinically and immunopathogically different? A review in Brazil
Fernando T. Silveiraa
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2019)
First report of Leishmania (Viannia) lindenbergi causing tegumentary leishmaniasis in the Brazilian western Amazon region
Lilian Motta Cantanhede et al.
PARASITE (2019)
Chemotherapy of leishmaniasis: present challenges
Silvia R. B. Uliana et al.
PARASITOLOGY (2018)
Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial
Paulo R. L. Machado et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2018)
Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs
Alberto Rastrojo et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)
Case Report: Atypical Cutaneous Leishmaniasis in a Patient with Mixed Leishmania guyanensis and Leishmania amazonensis Infection
Carina Scolari Gosch et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Cutaneous Leishmaniasis Due to Leishmania aethiopica
Saskia van Henten et al.
ECLINICALMEDICINE (2018)
Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh
Ridwanur Rahman et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Species Typing in Dermal Leishmaniasis
Gert van der Auwera et al.
CLINICAL MICROBIOLOGY REVIEWS (2015)
Leishmania (Viannia) naiffi: rare enough to be neglected?
Giselle Aparecida Fagundes-Silva et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2015)
Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh
Kazi M. Jamil et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species
Eliane de Morais-Teixeira et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Susceptibility of clinical isolates of Leishrnania aethiopica to miltefosine, paromomycin, amphotericin B and sodium stibogluconate using amastigote-macrophage in vitro model
M. Utaile et al.
EXPERIMENTAL PARASITOLOGY (2013)
Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis
Afif Ben Salah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
In vitro Antileishmanial Drug Susceptibility of Clinical Isolates from Patients with Indian Visceral Leishmaniasis-Status of Newly Introduced Drugs
Vijay Kumar Prajapati et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2012)
Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use
Shyam Sundar et al.
CLINICAL INFECTIOUS DISEASES (2012)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
Randomized Controlled Clinical Trial to Access Efficacy and Safety of Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil
Anette Chrusciak-Talhari et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Antimony-Resistant Clinical Isolates of Leishmania donovani Are Susceptible to Paromomycin and Sitamaquine
Arpita Kulshrestha et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
Shyam Sundar et al.
LANCET (2011)
In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent
Karin Seifert et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Combination therapy for visceral leishmaniasis
Johan van Griensven et al.
LANCET INFECTIOUS DISEASES (2010)
Paromomycin: Uptake and resistance in Leishmania donovani
Anupam Jhingran et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2009)
Paromomycin
Robert N. Davidson et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2009)
Is Paromomycin an Effective and Safe Treatment against Cutaneous Leishmaniasis? A Meta-Analysis of 14 Randomized Controlled Trials
Dae Hyun Kim et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Infectivity of five different types of macrophages by Leishmania infantum
C. Maia et al.
ACTA TROPICA (2007)
Injectable paromomycin for visceral leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cutaneous leishmaniasis
Richard Reithinger et al.
LANCET INFECTIOUS DISEASES (2007)
American tegumentary leishmaniasis:: Is antimonial treatment outcome related to parasite drug susceptibility?
Vanessa Yardley et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Treatment of visceral leishmaniasis
S Sundar et al.
EXPERT OPINION ON PHARMACOTHERAPY (2005)
Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis
GS Gonçalves et al.
ACTA TROPICA (2005)
Nitric oxide partially controls Coxiella burnetii phase II infection in mouse primary macrophages
DS Zamboni et al.
INFECTION AND IMMUNITY (2003)
Oral miltefosine for Indian visceral leishmaniasis
S Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala
BA Arana et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2001)
Share Paper
